Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cryo Cell International (CCEL) Gross Margin (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Gross Margin for 16 consecutive years, with 77.89% as the latest value for Q4 2025.

  • On a quarterly basis, Gross Margin fell 54.0% to 77.89% in Q4 2025 year-over-year; TTM through Nov 2025 was 76.63%, a 148.0% increase, with the full-year FY2025 number at 76.63%, up 148.0% from a year prior.
  • Gross Margin was 77.89% for Q4 2025 at Cryo Cell International, up from 76.98% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 78.43% in Q4 2024 to a low of 67.23% in Q3 2021.
  • A 5-year average of 72.99% and a median of 73.09% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: plummeted -368bps in 2021, then skyrocketed 412bps in 2024.
  • Cryo Cell International's Gross Margin stood at 68.62% in 2021, then increased by 6bps to 72.45% in 2022, then increased by 3bps to 74.31% in 2023, then rose by 6bps to 78.43% in 2024, then fell by -1bps to 77.89% in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Gross Margin are 77.89% (Q4 2025), 76.98% (Q3 2025), and 76.58% (Q2 2025).